Clinical Trials
ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com
Anaqua’s ideaPoint, a leading provider of innovation management solutions, has announced a partnership with SAS, the world leader in analytics. The partnership will provide to pharmaceutical companies and academic researchers the most robust clinical trial data sharing solution, with...
Clinical Trials
Clariant has agreed to sell its Masterbatches business for approx. USD 1.6 billion
Clariant, a focused and innovative specialty chemical company, has agreed to sell its entire Masterbatches business to PolyOne. The transaction values the Masterbatches business at USD 1,560 million, representing c. 12.2 times the last twelve months reported EBITDA (ending...
Clinical Trials
Symbiosis invests $1.5 million in UK facility expansion
Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.
In the last 12 months Symbiosis has invested over £1.5m ($1.9m) in...
Clinical Trials
Janssen to Acquire Investigational Bermekimab from XBiotech
Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in...
Clinical Trials
Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients and hospitals in Uruguay
Eugen, a clinical development service provider based in Uruguay, will support Clinerion’s expansion by promoting hospitals in the country to join Patient Network Explorer (PNEx), adding to the platform true global representativeness.
They will use PNEx to provide clients with...
Clinical Trials
ImmuPharma signs agreement with Avion for Lupuzor
UK-based pharmaceutical company ImmuPharma has signed a licensing and development agreement with US-based Avion Pharmaceuticals for Lupuzor, a peptide therapeutic and a first-in-class autophagy immunomodulator for auto-immune disease systemic lupus erythematosus (SLE or lupus).
Under the agreement, the two firms...
Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, announce the signing of an exclusive clinical trial supply agreement for oncology generics.
Through...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
